Genetic Diversity of Drug-Related Genes in Native Americans of the Brazilian Amazon

Fernandes, MR ; Rodrigues, JCG ; Maronas, O ; Latorre-Pellicer, A (Universidad de Zaragoza) ; Cruz, R ; Guerreiro, JF ; Burbano, RMR ; de Assumpcao, PP ; Ribeiro-dos-Santos, A ; dos Santos, SEB ; Carracedo, A ; dos Santos, NPC

Resumen: Introduction: The genetic admixture of the Brazilian population has considerable relevance to the implementation of the principles of pharmacogenomics (PGx), as it may compromise the extrapolation of data obtained in more homogeneous world populations. Purpose: This study aims to investigate a panel of 117 polymorphisms in 35 pharmacogenes, which contains label recommendations or clinical evidence by international drug regulatory agencies, in Amazonian Native American populations, and compare the results obtained with continental population data from the 1000 Genomes Project Consortium. Patients and Methods: The study population is composed of 109 Native American individuals from three Brazilian Amazon groups. The genotyping of the PGx polymorphisms was performed by allelic discrimination using TagMan (R) OpenArray Genotyping with a panel of 120 customized assays on the QuantStudio (TM) 12K Flex Real-Time PCR System. Results: Statistical differences within the Native American populations were observed regarding both genotypes and phenotypes of some genes of the CYP family. The discriminant analysis of principal components (DAPC5) between the NAM group and the continental populations of the 1000 Genomes Project resulted in the clustering of the three Native American populations. Additionally, in general, the NAM group was determined to be closely situated between East Asia, America, and South Asia groups, which enabled us to infer a genetic similarity between these populations. The DAPC analysis further demonstrated that eight polymorphisms and six polymorphisms were more relevant in differentiating the NAM from the continental populations and the NAM populations among themselves, respectively. Conclusion: Some investigated polymorphisms show differences among world populations, particularly with populations of European origin, for whom precision medicine protocols are primarily designed. The accumulated knowledge regarding these variations may assist in the design of specific protocols for Native American populations and populations admixed with them.

Idioma: Inglés

DOI: 10.2147/PGPM.S274741

Año: 2021

Publicado en: Pharmacogenomics and Personalized Medicine 14 (2021), 117-133
ISSN: 1178-7066

Factor impacto JCR: 2.606 (2021)

Categ. JCR: PHARMACOLOGY & PHARMACY rank: 197 / 279 = 0.706 (2021) - Q3 - T3

Factor impacto CITESCORE: 3.0 - Pharmacology, Toxicology and Pharmaceutics (Q3) - Biochemistry, Genetics and Molecular Biology (Q3)

Factor impacto SCIMAGO: 0.683 - Pharmacology (Q2) - Molecular Medicine (Q2)

Tipo y forma: Artículo (Versión definitiva)

Área (Departamento): Área Fisiología (Dpto. Farmac.Fisiol.y Med.L.F.)